Monoclonal antibody-based therapeutics have become increasingly significant in the field of medicine, offering targeted and precise treatments for various diseases.
Hematologic malignancies (blood cancers) are diseases of immune system cells and are traditionally categorized according to where the cancer is first detected; in the blood (leukemias), lymph nodes (Hodgkin and non-Hodgkin lymphomas) or bone marrow (myelomas).